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The differential regulation of cAMP levels within the oocyte and somatic (cumulus) cell compartments of the bovine
follicle, and the subsequent regulation of oocyte meiotic maturation was examined through specific cell-type localisation
of phosphodiesterases (PDEs). Selective PDE inhibitors were used to modulate cAMP levels in each of the two follicular
compartments and to examine their effects on oocyte meiotic maturation. Ovaries were obtained from an abattoir and
cumulus-oocyte complexes (COC) were aspirated from antral follicles into culture medium supplemented with 4 mg/ml
BSA and 2mM 3-isobutyl-1-methylxanthine (IBMX). COC, denuded oocytes (DO), or mural granulosa cells (MGC) were
cultured either with or without forskolin or FSH, in the presence of specific PDE inhibitors; either milrinone (PDE3
inhibitor), cilostamide (PDE3 inhibitor), or rolipram (PDE4 inhibitor). COC/DO cultures were assessed for meiotic
progression and cAMP content, and MGC for cAMP production. The type 3 PDE inhibitor, but not the type 4, prevented
spontaneous meiotic maturation and elevated intraoocyte cAMP in cultured denuded oocytes. In contrast, the type 4 PDE
inhibitor had no effect on the oocyte, but elevated mural granulosa and cumulus cell cAMP production. The results of this
study indicate that specific PDE subtypes are differentially localised within the two compartments of the bovine
follicle—the type 3 PDE in the oocyte and the type 4 PDE in the granulosa cells. In addition, oocyte cAMP levels are
primarily regulated in bovine oocytes by its degradation by PDE, whereas granulosa cell cAMP levels are controlled mainly
by active adenylate cyclase, with both sources able to participate in oocyte meiotic regulation. © 2002 Elsevier Science (USA)
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The exact mechanisms and signals that regulate mamma-
lian oocyte meiotic maturation have not been fully eluci-
dated. In nonatretic follicles, oocytes remain at the germi-
nal vesicle (GV) stage unless exposed to the preovulatory
surge of luteinising hormone (LH) during each ovarian
cycle. The oocyte in the dominant follicle(s) then resumes
meiosis, undergoing germinal vesicle breakdown (GVBD)
and proceeds through metaphase I (MI), only to be subse-
quently rearrested at the metaphase II (MII) stage of meio-
sis. Alternately, mechanical isolation of the oocyte from an
antral follicle induces spontaneous meiotic resumption in
vitro without the requirement for gonadotrophic hormonal
stimulation. Experimental results such as these implicate
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All rights reserved.the follicular environment in maintaining the oocyte in
meiotic arrest, probably via inhibitory factors produced by
the follicle, the suppression of a stimulatory molecule, or
by a combination of both (Downs, 1996).
There is abundant evidence that the second messenger
cyclic adenosine mono-phosphate (cAMP) plays an important
role in maintaining meiotic arrest in rodent oocytes. The role
of cAMP in the control of meiosis is less clearly demonstrated
in bovine oocytes. Several agents that experimentally elevate
oocyte cAMP transiently inhibit the spontaneous matura-
tion of bovine oocytes isolated from their follicles in vitro.
These include membrane permeable derivatives of cAMP
such as dibutyryl-cAMP (dbcAMP) and 8-bromo-cAMP (Ak-
tas et al., 1995b; Homa, 1988; Sirard and First, 1988),
phosphodiesterase (PDE) inhibitors (Bilodeau et al., 1993;
Mayes, 2000; Sirard and First, 1988), forskolin—a stimula-
tor of adenylate cyclase (Homa, 1988; Sirard, 1990), and
invasive adenylate cyclase (iAC) (Aktas et al., 1995a,b).
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In contrast, meiotic resumption is induced in follicle-
enclosed rodent oocytes following injection of cAMP ana-
logues into the follicular antrum (Tsafriri et al., 1972), or
exposure of the follicles to dbcAMP (Hillensjo et al., 1978),
phosphodiesterase inhibitors (Dekel et al., 1981), or forsko-
lin (Yoshimura et al., 1992). These studies indicate that
LH-induced oocyte maturation is a cAMP-mediated re-
sponse, however the continuous presence of cAMP, cAMP
analogues, and PDE inhibitors in the culture medium of
isolated oocytes prevent their spontaneous maturation in
culture.
These apparently opposing actions of cAMP present a
contradiction: a rise in follicular cAMP mediates LH-
induced meiotic maturation, but a rise in intraoocyte cAMP
maintains oocyte meiotic arrest. A hypothesis to explain
this paradox proposes that cAMP is compartmentalised
within the follicle and is differentially regulated within the
two compartments—the germ cell (oocyte) and the somatic
(cumulus) cells due to the differential localisation of dis-
tinct phosphodiesterase (PDE) subtypes (Tsafriri et al.,
1996).
Mammalian PDEs currently constitute 11 distinct fami-
lies of isoenzymes (PDE1–11), which consist of at least 20
gene types (Conti and Jin, 2000; Fawcett et al., 2000). PDE
isoenzymes are differentially expressed and regulated in
different cellular and tissue locations (Nicholson et al.,
1991) and have a similar structural layout, with a conserved
catalytic domain and a distinct regulatory domain, which
confers the specific regulatory characteristics of the differ-
ent PDE families (Kenan et al., 2000). Compartmentalisa-
tion of two PDE types has been demonstrated in rat fol-
licles, where PDE3A has been localised only to the oocyte
and PDE4D and 4B to mural granulosa cells, theca and
interstitial tissue only (Reinhardt et al., 1995; Tsafriri et al.,
1996).
Nonspecific PDE inhibitors such as 3-isobutyl-1-methyl-
xanthine (IBMX) and hypoxanthine have been used exten-
sively to investigate the mechanisms underlying the regu-
lation of meiotic maturation (for a review see (Downs, 1996;
Eppig, 1993). However, the availability of subtype-specific
PDE inhibitors provide a new opportunity for more exten-
sive examination of oocyte maturation and represent new
and powerful experimental tools for investigating oocyte-
follicular cell interactions. Selective regulation of the ac-
tivities of follicular PDE subtypes may account for the
apparently paradoxical role of cAMP, and may provide
further insight into the mechanisms of oocyte meiotic
control. To date there are only a limited number of studies
using type-specific PDE inhibitors to study the regulation of
oocyte and follicular cell function, firstly in Xenopus
(Sadler, 1991), and recently in rodent (Gilchrist et al., 2001;
Tsafriri et al., 1996; Wiersma et al., 1998) and bovine
(Mayes, 2000) oocytes.
Induction of oocyte maturation is associated with in-
creased follicular cAMP levels although intraoocyte cAMP
has been observed to decrease before germinal vesicle
breakdown. The aim of this study was to examine whether
the differential regulation of cAMP levels within the oocyte
and somatic (cumulus) cell compartments of the follicle
controls bovine oocyte meiotic maturation through specific
cell-type localisation of phosphodiesterases (PDEs). Specific
PDE isoenzyme inhibitors were used to modulate cAMP
levels in one of the two follicular compartments and to
examine their effects on oocyte meiotic maturation.
MATERIALS AND METHODS
Collection and Preparation of Bovine Oocytes
Bovine ovaries were obtained at an abattoir and transported to
the laboratory in a thermos bottle containing warm (29–32°C)
saline (0.9% w/v NaCl supplemented with penicillin G (40 IU/ml;
Sigma, St Louis, MO, USA) and streptomycin sulphate (40 g/ml;
Sigma), requiring 3–4 h for collection and transport. All ovaries
collected on a day were pooled and used at random. Follicle
aspiration was performed with an 18-gauge needle and a 10 ml
syringe. Follicular contents were aspirated from follicles2–8 mm
in diameter of unknown atresia status and transferred to 15 ml
conical tubes (Falcon, Franklin Lakes, NJ, USA) containing 4 ml
25mM HEPES-buffered tissue culture medium-199 (H-TCM; ICN
Biomedicals, CA, USA) supplemented with sodium pyruvate
(2mM; Sigma), penicillin G (100IU/ml), streptomycin sulfate (100
g/ml), bovine serum albumin (BSA, fraction V; 4 mg/ml; Sigma),
and 3-isobutyl-1-methyl-xanthine (IBMX; 5mM; Sigma). The aspi-
rate was left to sediment when total volume reached 10 ml.
Follicular fluid was supplemented with the meiotic inhibitor IBMX
to prevent premature commitment to meiotic progression during
the collection of oocytes, and subsequent removal of inhibitors
does not change the frequency of maturation and development
(Aktas et al., 1990).
Cumulus-oocyte complexes (COCs) with an intact, compact
cumulus investment were selected under a dissecting microscope
and transferred to 35 mm Petri dishes (Falcon) containing H-TCM
 2mM IBMX for counting. Where specified, COCs were mechani-
cally denuded in 0.5 ml H-TCM  IBMX (2 mM) before or after
culture using vigorous pipetting to remove all cumulus cells
surrounding the oocytes. COCs were washed twice in H-TCM, and
then transferred to dishes containing bicarbonate-buffered TCM-
199 (B-TCM) supplemented with sodium pyruvate (0.23 mM),
antibiotics and BSA (4 mg/ml) before being transferred to respective
treatments.
Oocyte Culture
Groups of up to 60 COCs or denuded oocytes (DOs) were
transferred in 50 l of B-TCM to individual wells of 4-well multi
dishes (Nunc, Denmark). Inhibitors and other agents, diluted in
B-TCM, were then added to give a final volume of 500 l.
Replicates of each experiment utilised an average of 90 COCs or
DOs per treatment group. Putative meiotic inhibitors were added
alone or in combination, these being the nonspecific phosphodies-
terase (PDE) inhibitor IBMX, type 3 PDE specific inhibitors milri-
none (MR; Sigma) and cilostamide (CM; ICN Biomedicals), the type
4 PDE specific inhibitor rolipram (RP; Sigma), and the adenylate
cyclase stimulator forskolin (FK; Sigma). Because FSH induces
cumulus cell expansion, accompanied by breakdown of gap junc-
tional communication with the oocyte, disrupting possible passage
of cAMP from the cumulus cells into the oocyte (Eppig, 1991),
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forskolin was used as an alternative to rhFSH because of its ability
to stimulate the catalytic subunit of oocyte adenylate cyclase
directly. Millimolar stock concentrations of PDE inhibitors were
stored at 20°C dissolved in dimethyl-sulphoxide (DMSO; Sigma)
and solutions containing inhibitor were diluted fresh for each
experiment. The final concentration of DMSO in any treatment
well was 0.1%. DMSO concentration of 3% or greater per
treatment well inhibited spontaneous maturation of bovine COC
and DO in a dose dependant manner (3%: 20%GV; 15%:
100%GV; unpublished results). All COCs and DOs were cultured
in B-TCM  BSA for either 5 or 16h at 39°C, 96% humidity in an
atmosphere of 5% CO2 in air.
Oocyte Meiotic Assessment
At the end of the incubation, COCs were denuded as described
above. Oocytes to be assessed for meiotic status were transferred to
a fixing solution (3:1 ethanol: acetic acid) for 24 h before staining
with 1% Orcein (Sigma). Fixed oocytes were then mounted on
slides and compressed beneath a cover slip supported by petroleum
jelly and retained with glue. Oocytes were examined with a phase
contrast microscope at 400 and classified as being at either
germinal vesicle (GV), diakinesis I, metaphase I (MI), anaphase I,
telophase I or metaphase II (MII) stages (Homa, 1988; Motlik et al.,
1978). For graph simplicity, those oocytes at diakinesis I were
pooled with and classified as MI, and those at anaphase I and
telophase I were pooled with and classified as MII. Approximately
10% of oocytes that were denuded before culture were at the GV
stage and of a degenerative appearance upon meiotic assessment
and were consequently not included in the final assessment.
Granulosa Cell Preparation and Culture
Ovary collection and follicular fluid aspiration was performed as
described above. All debris (stromal and thecal tissue, preantral
follicles, and oocytes) was removed from the follicular fluid and the
remaining aggregated mural granulosa cells (MGCs) transferred to
a separate tube. MGCs were collected by centrifugation for 5 min
and the supernatant discarded. MGCs were washed once in H-TCM
 BSA and twice in B-TCM  BSA. A 100 l aliquot of the washed
cells was removed and cells dissociated (Luciano et al., 2000) to
permit accurate counting by haemocytometer to determine MGC
concentration. Aggregated undissociated MGCs were cultured at a
density of approximately 1 105 cells/well and a final well volume
of 250 l gave a final cell density of 4  105 cells/ml.
MGCs were treated in duplicate with or without recombinant
human follicle-stimulating hormone (rhFSH, Gonal-F, Serono,
French’s Forest, NSW, Australia) or forskolin (FK), and the type 3
specific PDE milrinone (MR), type 4 specific PDE inhibitor rolip-
ram (RP), and nonspecific PDE inhibitor (IBMX). Depending on
treatments of individual experiments, hormones, inhibitors, and
B-TCM were added to wells of a 96-well flat bottomed plate
(Falcon) to make up final volume of 250 l. Cells were cultured in
an atmosphere of 39°C, 96% humidity with 5% CO2 in air for 24 h.
At the completion of culture, 200 l of supernatant was removed
and frozen (20°C) for cAMP analysis.
Measurement of cAMP
Cyclic AMP content of COC, complex-derived oocytes (CDO),
DO and supernatants of granulosa cell cultures were measured
using a radioimmunoassay method described and validated previ-
ously (Reddoch et al., 1986). CDO (COCs cultured with their
cumulus mass intact and then denuded before assay) were used to
evaluate the effect of the surrounding cumulus cells on intraoocyte
cAMP concentrations. After 5 h of culture, 6–10 COC, 10–16
CDO, and 16–24 DO were washed in H-TCM  2mM IBMX,
transferred to 0.5 ml of ethanol (100%) and stored at 20°C. Before
cAMP measurements, samples were vortex agitated for 30 s and
then centrifuged at 3000g for 15 min at 4°C. Briefly, supernatants
were removed, evaporated, resuspended in assay buffer (50mM
sodium acetate, pH 5.5) and assayed following acetylation [the
addition of triethylamine (AJAX Chemicals, Sydney, Australia) and
acetic anhydride (BDH Laboratory Supplies, Poole, England) 2:1
v/v] and appropriate dilution. For assay of cAMP produced by
MGCs after culture, media was removed from wells and stored
at 20°C until diluted, acetylated, and assayed. 125I-labelled
cAMP (specific activity of 2175 Ci/mM, prepared by iodinating
2-0-monosuccinyladenosine-3:5-cyclic monophosphate tyrosyl
methyl ester (Sigma) using the chloramine T method (Hunter,
1970) and cAMP antibody (as prepared by Reddoch et al., (Reddoch
et al., 1986) were added and duplicate samples covered and left
overnight at 4°C. The following day, 1 ml cold 100% ethanol was
added and the samples were centrifuged at 3000g. The supernatant
was removed and the pellet dried and counted using a gamma
counter. Triplicate samples were used to produce a standard curve
(0–800 fmol cAMP).
Statistical Analysis
Differences in the proportion of oocytes within each preparation
(COC and DO) at each of the meiotic stages (GV, MI, MII) were
examined using Chi-squared analysis. Differences in cAMP produc-
tion by MGCs were assessed using multifactorial ANOVA analysis
(SAS package) and a Waller-Duncan K-ratio t-test to determine
individual differences between treatments. Differences between
intracomplex or intraoocyte cAMP measurements were deter-
mined following natural logarithmic transformation of data using a
one-way ANOVA and differences between treatment means tested
using Student-Newman-Keuls post hoc comparisons. Probabilities
of less than 0.05 were considered statistically significant.
RESULTS
Effect of Type 3 and 4 PDE Isoenzyme Inhibitors
on Spontaneous Maturation
The proportion of DO maintained at the immature GV
stage of meiosis did not increase with increasing concen-
trations of the type 3 PDE inhibitor, however, the propor-
tion of oocytes reaching MII decreased significantly with
increasing doses of the inhibitor (Fig. 1). Rolipram treat-
ment alone, even at the highest concentration of 500 m,
did not maintain any DO at the GV stage. Progression of
rolipram-treated DO from MI to MII was not inhibited at
concentrations of 50 or 250 m, however, the proportion
reaching MII after treatment with the very high concentra-
tion of 500 m was significantly decreased. This is likely
due to nonspecific effects of the PDE4 inhibitor on oocyte
PDEs—an effect observed by a previous study where PDE
type 4 and 5 specific inhibitors suppressed mouse oocyte
maturation at concentrations 200–500 times higher than
that of the type 3 inhibitor (Wiersma et al., 1998).
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The type 3 PDE inhibitor milrinone, but not the type 4
PDE inhibitor rolipram, inhibited GVBD in an increased
proportion of COCs (13% GV) compared to control-treated
COCs cultured for 16 h (0% GV; Fig. 2A). Similarly, DO
GVBD was prevented by milrinone at a frequency compa-
rable to that in COCs (18% GV; Fig. 2B), but was unaffected
by treatment with rolipram. In addition to its effects on
GVBD, treatment by milrinone, but not rolipram, signifi-
cantly delayed the progress of spontaneous maturation,
causing a decreased proportion of both COCs and DOs from
reaching MII stage (44% and 45%, respectively) compared
to controls (84 and 72% MII, respectively). The ability of
milrinone to inhibit meiosis in both COCs and DOs sug-
gests the absence of cumulus cells has no consequence on
its meiotic inhibitory capacity.
Inclusion of the type 3 PDE inhibitor in the culture
maintains a proportion—but not all oocytes—at the GV
stage. This suggests PDE inhibition alone may not be
sufficient to maintain a significantly elevated level of
intraoocyte cAMP—possibly due to an insufficient level of
endogenous oocyte adenylate cyclase activity. Forskolin
treatment of COCs and DOs prevented GVBD in a greater
proportion of oocytes compared to those that were cultured
in control medium (Figs. 2A and 2B). Only 25% of COCs
reached the MII stage following forskolin treatment com-
pared to 46% of forskolin-treated DOs (P  0.017). Com-
bined treatment with forskolin and milrinone maintained a
significantly greater proportion of COCs (43%GV) and DOs
(35% GV) at the GV stage when compared to treatment
with milrinone alone. Combined forskolin-milrinone treat-
ment delayed meiotic progression through to metaphase II
in COCs much more effectively than in DOs (MI: COC
48%; DO 27%; P  0.0132) (MII: COC 9%; DO 38%; P 
0.0001). While combined forskolin and rolipram treatment
prevented GVBD at a greater frequency (38% GV) than
either agent alone in COCs (Fig. 2A), this was not the case
in DO (9% GV; Fig. 2B).
FIG. 2. Effect of the type 3 (milrinone; 50 m) and type 4
(rolipram; 50 m) PDE inhibitors on the spontaneous meiotic
maturation of cumulus- oocyte complexes (A) and denuded oocytes
(B) following a 16 h culture period. Oocytes were cultured in
milrinone- or rolipram-supplemented culture media with or with-
out forskolin and were then assessed for meiotic progression and
classified as GV, MI, or MII stage. A mean number of 80 oocytes
were used in each treatment group from three replicate experi-
ments. Means within the same meiotic stage and with no common
superscripts are significantly different (Chi squared analysis, P 
0.05).
FIG. 1. Effect of increasing doses of the type 3 (milrinone; 50 m)
and type 4 (rolipram; 50 m) PDE inhibitors on the spontaneous
meiotic maturation of denuded oocytes following a 16 h culture
period. Oocytes were cultured in milrinone- or rolipram-
supplemented culture media and were then assessed for meiotic
progression and classified as GV, MI, or MII stage. A mean number
of 90 oocytes were used in each treatment group from three
replicate experiments. Means within the same meiotic stage and
with no common superscripts are significantly different (Chi
squared analysis, P  0.05).
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Effect of Two Different PDE3 Subtype Inhibitors
on the Spontaneous Maturation of COCs and DOs
Bovine COCs and DOs were treated with two different
type 3 PDE inhibitors, milrinone and cilostamide. Treat-
ment of COCs with 50 m cilostamide resulted in a
significantly (P  0.05) higher frequency of oocytes main-
tained at the GV stage (20% GV) compared to those treated
with 50 m milrinone (7% GV; Table 1). A similar effect
was seen in DOs, although the inhibitory effects of both
type 3 PDE inhibitors—especially cilostamide—were more
pronounced in DOs than in COCs. Cilostamide also pre-
vented significantly (P 0.05) more COCs from progressing
through to the MII stage compared to milrinone treated
COCs. A similar, although not statistically significant
trend was also noted in DOs (Table 1).
Effect of Type 3 PDE Isoenzyme Inhibitor on the
Spontaneous Maturation of COCs Following
Extended Culture
The effect of increasing time of culture in milrinone-
supplemented medium on spontaneous maturation of bo-
vine COCs was examined (Fig. 3). Continued exposure of
COCs to milrinone for up to 36 h maintained approxi-
mately 15% of oocytes at the GV stage, but only transiently
inhibited progression to MII. At 16 h,35% of oocytes were
at the MI stage and 55% at the MII stage. With increasing
time in milrinone, the proportion at MI significantly de-
creased (P  0.05) while those in MII increased until at t 
36 h the proportions were 1% MI and 81% MII. There is a
significant linear relationship (Chi-Squared test for trend)
among t  16, 20, 24, 28, and 36 h MR treated oocytes and
the proportion of oocytes at both the MI and MII stages (P
0.0001). Control-treated oocytes were cultured for each of
the time points (line graphs; 16, 20, 24, 28, and 36 h), but
were omitted from the figure for graph simplicity (0% GV,
7% MI, and 93% MII).
Reversibility of Milrinone-Inhibition of
Spontaneous Maturation
The reversibility of milrinone inhibition of GVBD was
also examined by culture of COCs for an initial 16 h period
in milrinone-supplemented medium, followed by two
washes and culture for a subsequent 20 h in control me-
dium. In contrast to oocytes cultured in milrinone supple-
mented medium for the full 36 h (17% GV), the percent-
age of oocytes at the GV, MI, and MII stages were the same
for both milrinone (16 h)-control(20 h) and control (36
h)-treated oocytes (Fig. 3), indicating that the inhibitory
effect of milrinone on spontaneous meiotic progression was
completely reversible.
Effect of Type 3 and Type 4 PDE Inhibitors on the
cAMP Content of COC, CDO, and DO
In bovine oocytes, GVBD occurs after 6–9 h of culture
(Sirard et al., 1989). To test whether treatment of oocytes
FIG. 3. Effect of the type 3 (milrinone; 100 m) PDE inhibitor on
the spontaneous meiotic maturation of cumulus-oocyte complexes
following extended culture. COCs were cultured in control or
milrinone-supplemented media and cohorts of oocytes then fixed
and assessed for meiotic progression at 16, 20, 24, 28, and 36 h (line
graphs; data from 16 to 28 h control-treated oocytes have been
omitted for simplicity). In addition, oocytes were cultured in
milrinone-supplemented media for an initial 16 h before being
washed and transferred to control-media for a subsequent 20 h to
examine milrinone’s reversibility/toxic effects on meiosis. A mean
number of 80 oocytes were used in each treatment group from three
replicate experiments. Means in both the bar and line graphs
within the same meiotic stage with no common superscripts are
significantly different (Chi squared analysis, P  0.05).
TABLE 1
The Effect of Two PDE3 Inhibitors, Milrinone and Cilostamide,
on COC and DO Spontaneous Meiotic Maturation Following











Control 108 0a 10.2d 90.0h
COC Milrinone 90 6.7b 42.2e 51.1g
Cilostamide 103 20.4c 44.7e 35.0f
Control 80 0a 15.2d 84.8h
DO Milrinone 83 8.4b 38.6e 53.0g
Cilostamide 77 29.9c 33.8e 36.4f,g
* Different letter superscripts indicate significant treatment
differences (P  0.05) within the same meiotic stage (a-cGV, d-eMI,
f-hMII; Chi-square).
** Milrinone (MR; 50M), cilostamide (CM; 50 m).
*** A mean number of 90 oocytes were used in each treatment
group from three replicate experiments.
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with the type 3 PDE inhibitor milrinone prevents the
spontaneous GVBD and meiotic progression of isolated
oocytes by increasing intraoocyte cAMP, cAMP concentra-
tions were measured in cumulus-enclosed, complex-
derived, and denuded oocytes after 5 h of culture (Figs. 4 and
5). Oocytes were also treated with the type 4 PDE inhibitor
rolipram to determine whether its dissimilar effect on
nuclear maturation was due to a separate potency in inhib-
iting cAMP degradation.
Neither the type 3, nor the type 4 PDE inhibitor alone
elevated DO cAMP levels, even at the very high concentra-
tion of 500 m (Fig. 4). In combination with forskolin, the
PDE3 inhibitor elevated oocyte cAMP levels in a dose
dependant manner above that of forskolin alone (1.09 fmol
per oocyte), with a maximal concentration achieved at 250
m (4.46 fmol per oocyte). Forskolin treatment combined
with 500 m milrinone, the highest dose tested, did not
elevate cAMP above that of 250 m. The PDE4 inhibitor
failed to increase oocyte cAMP in combination with fors-
kolin, even after treatment with 500 m (Fig. 4).
Cumulus-oocyte complexes (COCs), oocytes cultured
and assayed with their cumulus mass intact, were used to
evaluate the effect of the PDE inhibitors on intracomplex
cAMP concentrations. Treatment of COCs with the type 3
PDE inhibitor milrinone and the type 4 PDE inhibitor
rolipram alone failed to elevate cAMP levels above that of
control-treated COCs (Fig. 5A). In contrast, treatment of
COCs with forskolin alone induced a 50-fold increase in
cAMP over that of control-treated COCs. Combined treat-
ment of COCs with forskolin and either milrinone or
rolipram failed to induce COC cAMP levels significantly
different to those complexes treated with forskolin alone,
although the numerical value of rolipram and forskolin
treatment combined was approximately double that for
forskolin alone or in combination with milrinone.
Complex-derived oocytes (cultured with their cumulus
mass intact and then denuded before assay) were used to
evaluate the effect of the surrounding cumulus cells on
intraoocyte cAMP levels (Fig. 5B). On average, control-
treated COCs (Fig. 5A) contained approximately 3.5 times
the amount of cAMP measured in similarly treated CDOs
(Fig. 5B). CDOs treated with either of the PDE inhibitors
alone did not induce an increase in oocyte cAMP above that
of the control (Fig. 5B). Forskolin treatment of CDOs alone
induced a 47-fold increase in the amount of oocyte cAMP
compared to that of control-treated CDOs. Treatment of
CDOs with the type 3 and 4 PDE inhibitors in combination
with forskolin failed to induce significantly different levels
of cAMP compared to forskolin alone (Fig. 5B). cAMP levels
in DOs treated with forskolin alone were not significantly
different from controls (Fig. 5C). However, milrinone treat-
ment of DOs in combination with forskolin produced
intraoocyte cAMP levels 3.9 and 2.8 times those levels
measured after treatment with milrinone alone and forsko-
lin alone, respectively (Fig. 5C). In contrast, combined
rolipram and forskolin treatment of DOs failed to induce
cAMP levels significantly different from that of controls.
These results suggest the type 3, but not the type 4 PDE
inhibitor, is able to elevate intraoocyte cAMP.
Effect of Type 3, Type 4, and Nonspecific PDE
Inhibitors on Mural Granulosa Cell cAMP
Synthesis
MGCs treated with either the type 4 PDE inhibitor or the
nonspecific PDE inhibitor combined with rhFSH caused a
significant (P  0.05) increase in the production of cAMP
above that of control-treated and type 3 PDE inhibitor-
treated granulosa cells (Fig. 6). No PDE inhibitor effects
were observed in the absence of rhFSH. Compared to
controls, combined treatment of 120 mIU rhFSH and roli-
pram induced a 2.5-fold increase in cAMP, and 120 mIU
rhFSH combined with IBMX induced an almost fourfold
increase in cAMP concentration in media from treated
granulosa cells. In contrast, the type 3 PDE inhibitor
milrinone in combination with high rhFSH concentrations
failed to significantly elevate cAMP production above that
of control-treated cells (Fig. 6).
A dose response of the type 4 PDE inhibitor in combina-
tion with three different concentrations of rhFSH (Fig. 7A)
and forskolin (Fig. 7B) increased production of cAMP by
MGCs with increasing concentrations of rolipram. Roli-
pram treatment alone, even at the highest concentration of
100 m, did not induce a significant increase in cAMP
production. MGCs treated with FSH or forskolin alone
FIG. 4. Effect of increasing concentrations of the type 3 (milri-
none) and type 4 (rolipram) inhibitors 	 forskolin (0.1 mM) on the
cAMP content of denuded oocytes following a 5 h culture period.
Oocytes were cultured in milrinone- or rolipram-supplemented
culture media with or without forskolin and were then assessed for
cAMP content. Values are expressed as the mean concentration of
cAMP per oocyte 	 SEM of three replicates using 19–24 DOs per
treatment replicate. Means with different superscripts indicate
significantly different amounts of cAMP between individual treat-
ments (One-way ANOVA, P  0.05).
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produced increased levels of cAMP, with the highest doses
producing levels 3.5- and 5.2-fold above that of control
treated cells, respectively. Rolipram combined with FSH or
forskolin dramatically elevated MGC cAMP production.
DISCUSSION
This study demonstrates that specific PDE subtypes have
differing activities within the two compartments of the
FIG. 5. Effect of the type 3 (milrinone; 10 m) and type 4 (rolipram; 10 m) PDE inhibitors 	 forskolin (0.1 mM) on the cAMP content
of three different types of oocytes following a 5 h culture period: those cultured and assayed with their cumulus investment intact (COCs)
(A); those cultured as COCs but denuded of their cumulus investment before assay (CDOs) (B); and those denuded of all cumulus cells
before culture and assay (DOs) (C). Oocytes of each of the three types were cultured in milrinone- or rolipram-supplemented culture media
with or without forskolin and were then assessed for cAMP content. Values are expressed as the mean concentration of cAMP per oocyte
or complex 	 SEM of three replicates using 4–7 COCs, 12–15 CDOs, and 21–24 DOs per treatment replicate. Means within the same
graph/oocyte type with different superscripts indicate significantly different amounts of cAMP between individual treatments (One-way
ANOVA, P  0.05).
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bovine follicle—the type 3 PDE in the oocyte and the type
4 PDE in the granulosa cells. The type 3 PDE inhibitor, but
not the type 4, prevented the resumption of spontaneous
meiotic maturation and elevated intraoocyte cAMP in
cultured denuded oocytes. In contrast, the type 4 PDE
inhibitor had no effect on the oocyte, but elevated mural
granulosa and cumulus cell cAMP production.
The PDE3, but not the PDE4 inhibitor, significantly
delayed the meiotic progression of both cumulus-oocyte
complexes and denuded oocytes, implying the bovine oo-
cyte contains an active, milrinone-sensitive PDE3. The
inhibitory effect of milrinone was not transient—those
oocytes arrested at the GV stage remained so for at least 36h
(the longest incubation time measured)—and was not due
to toxic effects on meiosis as indicated by its demonstrated
reversibility. The effectiveness of cilostamide (an alternate
PDE3 inhibitor) in preventing GVBD and delaying progres-
sion of meiosis to MII provides further evidence that the
inhibitory effect of milrinone is indeed due to inhibition of
PDE3 and not a nonspecific or artifactual effect. The ab-
sence of a PDE4 inhibitor effect on meiosis in denuded
oocytes is consistent with previously published results that
type 4 PDEs are found primarily in the somatic compart-
ment of the rodent follicle and not in the oocyte (Reinhardt
et al., 1995; Tsafriri et al., 1996).
Although evidence for the participation of cAMP-
dependant pathways in the maintenance of meiotic arrest is
compelling in rodents, the situation is more complex in
higher order mammals. Due to the similarity between PDE
subtype sequences across species (Conti and Jin, 2000), it is
likely that the presence of subtypes similar in regulation
and function should also act similarly in other mammalian
species. Despite this, rodent oocytes are experimentally
more responsive than those of ungulates to cAMP and its
analogues, as well as to inhibitors of PDEs (for a review see
(Schultz, 1991); rodent (Tsafriri et al., 1996; Wiersma et al.,
1998); bovine (Aktas et al., 1995a; Sirard and First, 1988).
FIG. 7. Effect of increasing doses of the type 4 PDE inhibitor
rolipram on the production of cAMP by mural granulosa cells in
response to stimulators of cAMP - (A) rhFSH and (B) forskolin.
Granulosa cells were cultured with increasing concentrations of
rolipram and three different concentrations of rhFSH or forskolin
for a 24 h incubation period. Values are expressed as mean 	 SEM
concentration of cAMP in the culture media after incubation. Each
point represents a mean of three replicates. Means with no com-
mon superscripts indicate significant differences between amount
of cAMP within an individual treatment (Fig. 5a: control(a), 13.3
mIU FSH(b–d); 40 mIU FSH(e–h) and 120 mIU FSH(i–j); Fig. 5b: control(a),
1 m FK(b); 10 m FK (c–d) and 100 m FK (e–h); One-way ANOVA,
SPSS package, P  0.05).
FIG. 6. Effect of the type 3 (milrinone; 10 m), type 4 (rolipram;
10 m), and the nonspecific (IBMX; 200 m) PDE inhibitors on the
production of cAMP by mural granulosa cells. Granulosa cells were
cultured with each of the PDE inhibitors and increasing concen-
trations of rhFSH for a 24 h-incubation period. Values are expressed
as mean 	 SEM concentration of cAMP in the culture media after
incubation. Each point represents a mean of three replicates. Means
with no common superscripts indicate significant differences be-
tween amount of cAMP within an individual treatment (control(a–d),
milrinone(e–g); rolipram(h–l) and IBMX(m–q); One-way ANOVA, SPSS
package, P  0.05).
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Bovine oocytes recovered from slaughterhouse ovaries are
extremely heterogeneous in terms of quality and develop-
mental competence, probably due to the mixed age, breed,
and reproductive status (i.e. follicle size, day of estrous
cycle, level of atresia and influence of dominant follicles) of
cows passing through the abattoir on a given day (Fry et al.,
1997; Machatkova et al., 2000). In our laboratory for ex-
ample, milrinone maintains 15% of bovine oocytes
(present study), but 80–90% of mouse oocytes at the GV
stage (Gilchrist et al., 2001) in vitro. Accordingly, the
reduced efficacy of PDE3 inhibitors in bovine compared to
rodent oocytes may be related to greater follicular hetero-
geneity typical for bovine studies using ovaries collected at
abattoirs.
Although adenylate cyclase has been localised to the
membrane of the bovine oocyte (Kuyt et al., 1988), in the
absence of stimulation its basal activity may be too low to
allow milrinone alone to elevate oocyte cAMP levels suffi-
ciently to maintain arrest of oocytes in GV stage. Combined
treatment of DO with forskolin and milrinone (but not
rolipram) increased oocyte cAMP. This is the first report
that distinct PDEs can selectively control cAMP levels in
the granulosa and germ cell compartments of the bovine
follicle, with PDE3 being active in the oocyte, and PDE4 in
the cumulus cells. This supports the finding in rodent
(Reinhardt et al., 1995; Tsafriri et al., 1996; Wiersma et al.,
1998) and preliminary observations in bovine (Mayes, 2000)
studies, that PDE subtypes are compartmentalised in the
bovine follicle and provides a mechanism for the differen-
tial regulation of cAMP through the compartmental expres-
sion of different phosphodiesterase subtypes.
Measurements of cAMP levels in oocytes exposed to the
various agents as DO and COC provide compelling evi-
dence for two sources of cAMP in the oocyte: one, inter-
nally generated (within the oocyte), with levels determined
by a balance between synthesis in the oocyte by adenylate
cyclase (weak stimulation by forskolin) and degradation by
PDE3 (inhibited by milrinone, but not rolipram); and two,
externally generated (from cumulus cells), where levels are
strongly stimulated by forskolin alone but are not greatly
influenced by either PDE inhibitor. Regulation of intraoo-
cyte cAMP apparently occurs primarily by control of its
degradation (by very active PDE3), rather than by endoge-
nous synthesis. While exposure of COC to forskolin in-
creased cAMP levels in both cumulus cells and CDO,
neither the PDE3 inhibitor milrinone, nor the PDE4 inhib-
itor rolipram altered basal or forskolin-stimulated cAMP
levels. Therefore, in contrast to intraoocyte cAMP level
regulation, cAMP levels in COC seem to be regulated
primarily by control of synthesis in the cumulus cells (by
very active adenylate cyclase)—with its degradation by
PDE4 being of lesser importance. The considerably higher
intraoocyte levels of cAMP achieved in CDO than in DO
indicate that cumulus cells are the major source, with
internally generated cAMP being quantitatively less impor-
tant. The transfer of cAMP from cumulus cells to oocyte
appears an efficient process, with approximately 25% of
that produced in COC in response to stimulation with FK
appearing in the CDO derived therefrom. As a consequence
of this efficient transfer, much higher levels of cAMP are
attained in oocytes derived from COC stimulated maxi-
mally with forskolin and rolipram combined (80 fmol/
oocyte) compared to DO maximally stimulated with fors-
kolin and milrinone combined (2 fmol/oocyte).
In attempting to relate observed changes in cAMP levels
to changes in meiotic stage attained under the various
treatments, account must be taken of the heterogeneity of
oocytes under study, as discussed above. It is evident that
only a minority of oocytes was capable of inhibition of
GVBD under the conditions of the study, irrespective of
treatment. Forskolin by itself reduced GVBD in a small
proportion of oocytes (10% of COC; 20% of DO), and only
approximately 40% of oocytes remained in GV stage when
exposed to FK  MR either as COC or as DO. Of the
remaining oocytes (those that underwent GVBD irrespec-
tive of treatment), the stage reached after 16 h in culture
differed depending on whether exposed to treatment as DO
or as COC. Just under half of those treated with FK and/or
MR as DO completed meiosis (reached MII stage), whereas
the majority of those exposed to FK  MR as COC pro-
ceeded only to MI stage during the 16 h culture. It is of
interest to relate these maturation results to maximal
intraoocyte cAMP levels attained during 5 h culture under
the same treatments; the cAMP level attained in DO when
maximally stimulated with FK  MR was 2 fmol/oocyte,
compared to approximately 70 fmol/oocyte when stimu-
lated as COC with FK  MR. These results suggest that a
(minor) subpopulation of the oocytes is capable of complete
inhibition of meiosis by treatments that result in a modest
increase in intraoocyte cAMP level of 2 fmol/oocyte. In
contrast, the majority of oocytes, which undergo GVBD
spontaneously irrespective of treatment, respond to consid-
erably higher cAMP levels (up to 80 fmol/oocyte) with
inhibition at a later meiotic stage.
An additional level of meiotic control has been proposed
in rodent oocytes, whereby the inhibitory effect of elevated
intraoocyte cAMP can be over-ridden by an uncharacterised
factor(s) of somatic cell origin, for example follicular fluid
meiosis-activating sterol (FF-MAS) secreted by follicular
somatic cells in response to gonadotrophic stimulation
(Byskov et al., 1997). Secretion of FF-MAS by rodent granu-
losa cells is itself a cAMP-dependent process. Although
direct evidence for FF-MAS in regulation of oocyte matura-
tion in nonrodent species is lacking, the results of our
studies may offer tenuous support for a similar mechanism
of meiotic control in bovine oocytes. Thus, the addition of
the PDE4 inhibitor rolipram to COC cultured with FK was
able to partially reverse the inhibitory effect of FK alone on
progression of maturation from MI to MII stage (Fig. 2A),
while eliciting an approximate doubling (albeit not statis-
tically significant) of mean cAMP levels attained in the
COC culture (Fig. 5). This finding, together with the lack of
a similar effect of combined FK  RP on either progression
of meiosis or cAMP levels in DO and CDO, is consistent
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with a role of factor(s) secreted by cumulus cells in response
to high levels of cAMP that override the meiosis-inhibiting
action of cAMP on completion of meiosis.
Measurements of cAMP production by mural granulosa
cells were consistent with those of cumulus cells, indicat-
ing that the follicular somatic cells contain the rolipram-
sensitive type 4 PDEs, but not the milrinone-sensitive type
3 PDEs. In conjunction with FSH or forskolin treatment,
cAMP production by mural granulosa cells was increased
by treatment with the PDE4 inhibitor rolipram and the
nonspecific PDE inhibitor IBMX, but not by those treated
with PDE3 inhibitor milrinone. Although the subtype-
specific localisation of PDEs has been confirmed in rodent
follicles using in situ hybridisation (Tsafriri et al., 1996),
the results of the present study are the first to demonstrate
this in a nonrodent species. In the absence of stimulation by
FSH or forskolin, granulosa cells did not produce increased
cAMP concentrations following treatment by any of the
PDE inhibitors.
In conclusion, this study has utilised the compartmental-
isation of PDE4 and PDE3 within the bovine follicle to alter
cAMP levels in the somatic and germ cell compartments,
respectively. The oocyte is responsive to the PDE3 inhibitor
but not the PDE4 inhibitor in terms of both cAMP and the
maintenance of meiotic arrest. On the other hand, the
granulosa cells respond to the PDE4, but not to the PDE3
inhibitor, and cumulus cell production of cAMP is a signifi-
cant contributor to the total cAMP content of the oocyte.
The selective PDE inhibitors are powerful experimental
tools to study the oocyte and surrounding cumulus cells in
separation, and to demonstrate the functions of specific
PDEs in regulation of cAMP levels in the two follicular
compartments. Such studies should provide new insights
into the fundamental mechanisms regulating mammalian
oocyte maturation, with potential for development of im-
proved methods of in vitro embryo production for assisted
reproduction applications in livestock and humans.
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